The text presents detailed financial information from Fiserv, Inc.'s consolidated financial statements, encompassing income statements, balance sheets, and cash flow statements for the three and nine months ended September 30, 2023 and 2022. It includes data on revenue, expenses, operating income, net income, comprehensive income, cash flows, assets, liabilities, and equity figures. The financial statements also elaborate on significant accounting policies and items such as cash equivalents, allowance for doubtful accounts, and prepaid expenses. Moreover, it delves into contract balances, transaction prices, acquisitions, and dispositions, covering details on intangible assets, investments in unconsolidated affiliates, and derivatives like forward exchange contracts. Additionally, it discusses revenue recognition, non-controlling interests, and other financial reporting considerations.
The text provides the "Management's Discussion and Analysis of Financial Condition and Results of Operations" of a company. It discusses forward-looking statements, significant risks and uncertainties, changes in critical accounting policies, results of operations by segment and their performance, liquidity and capital resources, share repurchases, acquisitions, dispositions, debt structure, covenants, compliance, and debt guarantees of the business. Additionally, it includes information on cash and cash equivalents, investments, and operational financial performance up to September 30, 2023.
The text discusses the concept of market risk and how it could lead to losses for financial instruments due to changes in various market factors like interest rates and currency exchange rates. The company actively monitors and manages market risks by using derivative instruments with creditworthy institutions. They specifically mention exposure to foreign currency exchange risks from non-U.S. operations in certain major currencies. The company's use of forward exchange contracts and other hedging instruments to manage risk is highlighted. For further details on market risks, reference to the Annual Report on Form 10-K for the year ended December 31, 2022 is suggested, with no significant changes reported in the analysis during the nine months ended September 30, 2023.
The text provided discusses the evaluation of disclosure controls and procedures as required by Rule 13a-15(b) under the Securities Exchange Act of 1934. The management, along with the chief executive officer and chief financial officer, assessed the design and functioning of these controls and procedures and concluded that they were effective as of September 30, 2023. There were no significant changes in the internal control over financial reporting during the three months ended September 30, 2023, that would have had a material impact on such controls.
The company and its subsidiaries are occasionally involved in lawsuits where claims are made against them. Management believes that any potential liabilities from these lawsuits will not have a significant negative impact on the company's consolidated financial statements.
I understand. Please go ahead and provide the text for me to summarize.
The text discusses information regarding purchases made by or on behalf of the company or affiliated purchasers of shares of common stock during the three-month period ending September 30, 2023. It includes details of the total number of shares purchased, average price paid per share, and the maximum number of shares that may yet be purchased under publicly announced plans or programs. The data shows specific numbers and dates along with authorizations by the board of directors for the purchase of shares of common stock without an expiration date.
Please send me the text parts that you would like me to summarize.
I'm sorry, but I am unable to summarize the text as I have not received any parts of the text. Please provide the text you'd like me to summarize.
During the three months ended September 30, 2023, most of the Company's directors and Section 16 officers did not adopt or terminate a Rule 10b5-1 Trading Plan or a "non-Rule 10b5-1 trading arrangement." However, on September 22, 2023, the Chief Financial Officer adopted a trading arrangement allowing the sale of securities of the Company's common stock until January 31, 2024. Similarly, on September 18, 2023, the Head of Global Business Solutions adopted a plan for the sale of a specific number of company shares until October 4, 2024.
The text provides details regarding the exhibits included in a Quarterly Report on Form 10-Q filed by Fiserv, Inc. The exhibit index lists various documentation including supplemental indentures, certifications of executives as per the Sarbanes-Oxley Act of 2002, Inline XBRL Instance Document, and Cover Page Interactive Data File among others. Additionally, it mentions the filing of Consolidated Financial Statements and notes in iXBRL format. The report is signed by the Chief Financial Officer and Chief Accounting Officer of Fiserv, Inc.
